COMMUNIQUÉS West-GlobeNewswire

Olema Oncology Announces New Preclinical Combination Data to be Presented at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

09/10/2024 - 13:00

Poster presentations include new preclinical data demonstrating activity for palazestrant in combination with capivasertib and everolimus, and OP-3136, Olema’s KAT6 inhibitor, in combination with palazestrant and other [...]

FDA Grants Orphan Drug Designation to Can-Fite’s Namodenoson for Pancreatic Cancer

09/10/2024 - 13:00

RAMAT GAN, Israel, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological [...]

Ocugen, Inc. Announces Removal of Clinical Hold on Investigational New Drug Application for OCU200 Phase 1 Clinical Trial

09/10/2024 - 12:30

MALVERN, Pa., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, [...]

Clearside Biomedical Announces Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieving All Primary and Secondary Outcomes

09/10/2024 - 12:30

- Maintained Stable Visual Acuity and Anatomical Control Over 9 Months - - Positive Safety Profile with No Ocular or Treatment-Related Serious Adverse Events - - 67% of CLS-AX Participants Did Not Require Any Additional [...]

Adagene Announces Upcoming Poster Presentations on Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) at Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

09/10/2024 - 12:00

SAN DIEGO and SUZHOU, China, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced poster [...]

Dentsply Sirona to Host Third Quarter Conference Call on November 7th

09/10/2024 - 12:00

CHARLOTTE, N.C., Oct. 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast [...]

Basecamp Research Initiates Genetic Medicine Collaboration with the Liu Laboratory and Completes $60 Million Series B Financing

09/10/2024 - 12:00

Basecamp Research’s industry-leading artificial intelligence platform trains on its proprietary data to design sophisticated biological solutions Collaboration with the Liu Lab to focus on next-generation genetic [...]

XORTX Initiates Precision Medicine Program

09/10/2024 - 11:00

Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine Metabolism CALGARY, Alberta, Oct. 09, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" [...]

Major shareholder announcement

09/10/2024 - 10:37

Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and [...]

AB Science annonce avoir réalisé le règlement livraison de sa dernière augmentation de capital de 5,0 millions d’euros

09/10/2024 - 08:26

COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE AVOIR REALISE LE REGLEMENT LIVRAISON DE SA DERNIERE AUGMENTATION DE CAPITAL DE 5,0 MILLIONS D’EUROS Paris, le 9 octobre 2024, 8h30 AB Science S.A. (la « Société » ou « AB Science [...]

Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases

09/10/2024 - 08:00

Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases Oversubscribed financing led by Sofinnova Partners in collaboration with Gilde Healthcare, Forbion, [...]

Press Release: New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infants

09/10/2024 - 07:00

New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infants Paris, October 9, 2024 . Sanofi advances its ambition to protect all infants from respiratory [...]

Communiqué de presse : De nouvelles données sur le Beyfortus présentées à l’IDWeek confirment son efficacité en situation réelle contre les infections dues au VRS et le risque d’hospitalisation chez les nourrissons

09/10/2024 - 07:00

De nouvelles données sur le Beyfortus présentées à l’IDWeek confirment son efficacité en situation réelle contre les infections dues au VRS et le risque d’hospitalisation chez les nourrissons Paris, le 9 octobre 2024 . [...]

Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

09/10/2024 - 05:55

SAN DIEGO, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]

Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

09/10/2024 - 02:00

HOUSTON, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ:BPTH) (“Bio-Path” or the “Company”), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology [...]

Zealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinism

09/10/2024 - 00:45

Company announcement – No. 48 / 2024 Zealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinism U.S. Food and Drug Administration (FDA) issues Complete Response Letter (CRL) for [...]

Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024

08/10/2024 - 23:43

SOUTH JORDAN, Utah, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial [...]

Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic

08/10/2024 - 23:32

Ongoing support of the ‘White House Challenge to Save Lives from Overdose’ through workplace and public safety measures One-year mark of Ready to Rescue public awareness campaign to expand awareness, particularly among [...]

ENCER Now Available on Amazon: A Game-Changer in Relief from Fatigue Related to Cancer Treatment

08/10/2024 - 22:29

Dr. Yakov Freed, developer of ENCER Photo credit: ENCER DOVER, Del., Oct. 08, 2024 (GLOBE NEWSWIRE) -- ENCER , the groundbreaking homeopathic remedy designed to provide relief from fatigue associated with cancer [...]